Alexandre Jose Bourcier
YOU?
Author Swipe
View article: Regenerating the epidural space: Promise and perspective on amniotic fluid for low back pain
Regenerating the epidural space: Promise and perspective on amniotic fluid for low back pain Open
View article: Spinal cord stimulation for Tarlov cyst-related pain: Initial success and subsequent explantation in an elderly patient
Spinal cord stimulation for Tarlov cyst-related pain: Initial success and subsequent explantation in an elderly patient Open
View article: 57 Understanding the Burden of Burn Injury in Latin America & the Caribbean
57 Understanding the Burden of Burn Injury in Latin America & the Caribbean Open
Introduction Burn injuries are a global health problem disproportionately affecting low- and middle-income countries, especially in Latin America and Caribbean (LAC) where cooking methods, dangerous work conditions, and minimal housing reg…
View article: Retrospective review of Google Trends to gauge the popularity of global surgery worldwide: A cross-sectional study
Retrospective review of Google Trends to gauge the popularity of global surgery worldwide: A cross-sectional study Open
GS is less popular than GH, more popular in high-income countries, and has become more popular after 2015 when the Lancet Commission on Global Surgery published its seminal report. The World Health Organization passed resolution WHA 68.15.…
View article: Qu´est-ce la chirurgie globale et quel est rôle des pays francophones dans la chirurgie globale ?
Qu´est-ce la chirurgie globale et quel est rôle des pays francophones dans la chirurgie globale ? Open
Les pays à faibles et moyens revenus sont les plus affectées par les maladies nécessitant une intervention chirurgicale ou obstétrique. Ainsi, 5 milliards de personnes n´ont pas accès à ces soins et ne possède pas les ressources nécessaire…
View article: Targeting IL-13Rα2 for effective treatment of malignant peripheral nerve sheath tumors in mouse models
Targeting IL-13Rα2 for effective treatment of malignant peripheral nerve sheath tumors in mouse models Open
OBJECTIVE Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive soft tissue sarcomas that harbor a high potential for metastasis and have a devastating prognosis. Combination chemoradiation aids in tumor control and decreases tu…
View article: MLN8237 treatment in an orthoxenograft murine model for malignant peripheral nerve sheath tumors
MLN8237 treatment in an orthoxenograft murine model for malignant peripheral nerve sheath tumors Open
OBJECTIVE Malignant peripheral nerve sheath tumors (MPNSTs) are soft-tissue sarcomas arising from peripheral nerves. MPNSTs have increased expression of the oncogene aurora kinase A, leading to enhanced cellular proliferation. This makes t…
View article: Tumor targeted delivery of doxorubicin in malignant peripheral nerve sheath tumors
Tumor targeted delivery of doxorubicin in malignant peripheral nerve sheath tumors Open
Peripheral nerve sheath tumors are benign tumors that have the potential to transform into malignant peripheral nerve sheath tumors (MPNSTs). Interleukin-13 receptor alpha 2 (IL13Rα2) is a cancer associated receptor expressed in glioblasto…
View article: TMOD-28. INTERLEUKIN-13 TARGETED PSEUDOMONAS TOXIN TREATMENT OF MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
TMOD-28. INTERLEUKIN-13 TARGETED PSEUDOMONAS TOXIN TREATMENT OF MALIGNANT PERIPHERAL NERVE SHEATH TUMORS Open
Malignant peripheral nerve sheath tumors (MPNSTs) are soft tissue sarcomas that arise from peripheral nerves. A target of MPNSTs is the receptor for interleukin-13 (IL-13R). IL-13R has an α1 and α2 subtype, and activation of α1 leads to ca…
View article: EXTH-13. IN VIVO THERAPEUTIC POTENTIAL OF IL13-LIPDXR IN A MALIGNANT PERIPHERAL NERVE SHEATH TUMOR MOUSE MODEL
EXTH-13. IN VIVO THERAPEUTIC POTENTIAL OF IL13-LIPDXR IN A MALIGNANT PERIPHERAL NERVE SHEATH TUMOR MOUSE MODEL Open
Malignant peripheral nerve sheath tumor is a soft tissue sarcoma that poses tremendous challenges for effective therapy. Several therapeutic approaches using drugs such as doxorubicin and rapamycin have been tried in the past with minimum …